The effect of TACE in combination with thalidomide-mediated adjuvant therapy on the levels of VEGF and bFGF in patients with hepatocellular carcinoma

CONCLUSION: TACE in combination with thalidomide-mediated adjuvant treatment has revealed a promising clinical outcome on HCC patients by downregulating the levels of VEGF and bFGF.PMID:34150160 | PMC:PMC8205699

Source: American Journal of Translational Research - June 21, 2021 Category: Research Authors: Chao Tong Hui Liu Rihui Chen Fengting Zhu Source Type: research